PT - JOURNAL ARTICLE AU - Elpis Hatziagorou AU - Vasiliki Avraamidiou AU - Maria Papagianni AU - Maria Karailidou AU - Dafni Papanikolaou AU - Despoina Terzi AU - Fotis Kirvassilis AU - Ioannis John Tsanakas TI - A “real life” study on height in prebupertal asthmatic children receiving inhaled steroids AID - 10.1183/13993003.congress-2016.PA1237 DP - 2016 Sep 01 TA - European Respiratory Journal PG - PA1237 VI - 48 IP - suppl 60 4099 - http://erj.ersjournals.com/content/48/suppl_60/PA1237.short 4100 - http://erj.ersjournals.com/content/48/suppl_60/PA1237.full SO - Eur Respir J2016 Sep 01; 48 AB - Introduction: Asthma is the most common chronic respiratory disease in children and inhaled steroids belong to the first-line treatment for these patients.Aim: To examine whether the administration of inhaled steroids in low or medium dose affect the prepubertal children's height.Methods: It was a retrospective study to assess the effects of inhaled steroids on growth in children with mild, persistent asthma. The comparison of height every 6 months from 3 to 8 years were conducted among three patients' groups: patients being treated without steroids, patients being treated with low dose of steroids and patients being treated with medium dose of steroids (GINA Guidelines 2015).Results: 284 patients (198 male) from 3 to 8 years old were included in the study. Seventy-five patients were not receiving steroids, 63 patients were on low dose steroids and 146 patients were on medium dose inhaled steroids. The measured height every 6 months didn't differed significantly (p>0.05) among three groups and the difference remains stable (p>0.05) even thought we studied males and females separately.Conclusion: In this “real life” study we found that a long term treatment with inhaled steroids in low or medium dose doesn't affect the height of prepubertal children with asthma.